Do biomarkers help to optimize therapy in inflammatory bowel disease?

被引：0

作者：

Vermeire, S. ^{[1
]}

机构：

[1] Univ Ziekenhuis Gasthuisberg, Gastroenterol Unit, B-3000 Louvain, Belgium

来源：

IMMUNOREGULATION IN INFLAMMATORY BOWEL DISEASES - CURRENT UNDERSTANDING AND INNOVATION | 2007年 / 153卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：55 / 60

页数：6

共 20 条

[1] THE CLINICAL-SIGNIFICANCE OF SERUM C REACTIVE PROTEIN-LEVELS IN CROHNS-DISEASE - RESULTS OF A PROSPECTIVE LONGITUDINAL-STUDY [J].

BOIRIVANT, M ;

LEONI, M ;

TARICIOTTI, D ;

FAIS, S ;

SQUARCIA, O ;

PALLONE, F .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 (04) :401-405

[2] A LABORATORY INDEX FOR PREDICTING RELAPSE IN ASYMPTOMATIC PATIENTS WITH CROHNS-DISEASE [J].

BRIGNOLA, C ;

CAMPIERI, M ;

BAZZOCCHI, G ;

FARRUGGIA, P ;

TRAGNONE, A ;

LANFRANCHI, GA .

GASTROENTEROLOGY, 1986, 91 (06) :1490-1494

[3]

Consigny Y, 2001, GASTROENTEROLOGY S, V20, pA53

[4] Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease [J].

Costa, F ;

Mumolo, MG ;

Ceccarelli, L ;

Bellini, M ;

Romano, MR ;

Sterpi, C ;

Ricchiuti, A ;

Marchi, S ;

Bottai, M .

GUT, 2005, 54 (03) :364-368

[5]

D'Incà R, 2005, GASTROENTEROLOGY, V128, pA307

[6] Optimizing immunomodulator therapy for inflammatory bowel disease [J].

Marla C. Dubinsky .

Current Gastroenterology Reports, 2003, 5 (6) :506-511

[7]

Feagan B, 2005, GASTROENTEROLOGY, V128, pA307

[8] A positive response to infliximab in Crohn disease: Association with a higher systemic inflammation before treatment but not with-308 TNF gene polymorphism [J].

Louis, E ;

Vermeire, S ;

Rutgeerts, P ;

De Vos, M ;

Van Gossum, A ;

Pescatore, P ;

Fiasse, R ;

Pelckmans, P ;

Reynaert, H ;

D'Haens, G ;

Malaise, M ;

Belaiche, J .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (07) :818-824

[9]

Niederau C, 1997, HEPATO-GASTROENTEROL, V44, P90

[10]

Pepys M B, 1977, Ciba Found Symp, P283

← 1 2 →